Skip to main content

Foreign Investment Control

Compliance with investment control reporting obligations under foreign trade and payments law, along with antitrust reporting obligations, is a central pillar for all investments in companies.

Why our lawyers?

We advise our clients comprehensively on all investment control law aspects.

We assist our clients with all questions related to the best structure of the transaction, the examination of existing reporting obligations, the notification to and communication with the competent authority, the Federal Ministry for Economic Affairs and Energy and the contractual hedging of risks.

With our international team, consisting of experienced and specialised lawyers and our cooperation partners, we are able to support you also in international transactions in all matters relating to investment control and related aspects in the areas of customs and antitrust law. 

Track record

As part of our investment control advice, we have supported our clients for example in the following projects:

Advising an internationally active company in the context of an in the consumer electronics sector. Coordination of worldwide investment control notifications in several European countries such as Austria, Russia and the United Kingdom, as well as in the United Arab Emirates and in several countries from the Asian and South American region;

Advising an international group on an internal restructuring of its corporate organisation. Coordination of various investment control notifications in the EMEA region (including Denmark, France, Italy, the United Kingdom and several Eastern European countries);

Advising on the acquisition of a stake in the critical raw materials sector. Assisting in the assessment procedure before the BMWK;

Advising a Chinese investor on the acquisition of joint control over a German automotive supplier. Assisting in the assessment procedure before the BMWK;

Advising on transactions in the telecommunications sector and in the area of cloud computing as well as on medical devices and the cast products sector.